oxybutynin has been researched along with Bladder Exstrophy in 1 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Bladder Exstrophy: A birth defect in which the URINARY BLADDER is malformed and exposed, inside out, and protruded through the ABDOMINAL WALL. It is caused by closure defects involving the top front surface of the bladder, as well as the lower abdominal wall; SKIN; MUSCLES; and the pubic bone.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Urinary incontinence is a debilitating problem that requires careful evaluation." | 1.31 | The management of urinary incontinence in the exstrophy complex, posterior urethral valves, and infrasphincteric ureters. ( Wilcox, DT, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wilcox, DT | 1 |
1 other study available for oxybutynin and Bladder Exstrophy
| Article | Year |
|---|---|
The management of urinary incontinence in the exstrophy complex, posterior urethral valves, and infrasphincteric ureters.
Topics: Bladder Exstrophy; Catheterization; Child; Cholinergic Antagonists; Epispadias; Female; Humans; Inte | 2002 |